Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Sanaria Inc. and the Government of Equatorial Guinea last week signed an agreement that continues their joint commitment to develop Sanaria® PfSPZ...
Building upon publication of clinical trial results in Nature, PNAS, Lancet Infectious Diseases, and JCI Insight in 2017, Sanaria Inc. is...
In a report published today in The Lancet Infectious Diseases, (Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous...
In einem heute in der wissenschaftlichen Fachzeitschrift The Lancet Infectious Diseases veröffentlichten Bericht (Safety and efficacy of PfSPZ...
Dans un rapport publié aujourd'hui dans The Lancet Infectious Diseases, intitulé « Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum ...
En un informe publicado hoy a través de The Lancet Infectious Diseases (Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct ...
In a report published today in Nature, (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine) investigators from the University...
In einem heute in Nature veröffentlichten Artikel (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine – Steriler Schutz gegen...
Dans un rapport publié aujourd'hui par le magazine Nature, (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine ou Protection...
En un informe publicado hoy en Nature, (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine), los investigadores de la...
Sanaria Inc. continues to achieve success in its coordinated efforts to develop a safe, effective and affordable vaccine that delivers protection...
Sanaria Inc. anunció hoy que ha recibido la designación de aprobación rápida (Fast Track) de la Administración de Alimentos y Fármacos (FDA) de EE....
Sanaria Inc. hat heute bekannt gegeben, dass es von der US-Arzneimittelbehörde FDA den Status „Fast Track" für Sanaria® PfSPZ erhalten hat, seine...
Sanaria Inc. a annoncé aujourd'hui qu'elle avait obtenu la désignation dite Fast Track de la U.S. Food and Drug Administration (FDA) pour son vaccin...
Sanaria Inc. today announced it has received U.S. Food and Drug Administration (FDA) Fast Track designation for its preventative vaccine for malaria, ...
Results of a clinical trial of Sanaria® PfSPZ (Plasmodium falciparum sporozoite) Vaccine to prevent malaria infections, published today in the online ...
The Government of the Republic of Equatorial Guinea announced an agreement with industry partners, Marathon Oil Corporation, Noble Energy Inc. and...
Biotechnology company Sanaria Inc. aims to raise at least $250,000 in 30 days on Indiegogo.com, a crowdfunding website. The campaign launches on May...
Sanaria received the 2014 Vaccine Industry Excellence Award for the "Best Prophylactic Vaccine" at a ceremony held March 25 in Washington DC during...
Sanaria Inc., a privately held company in Rockville, Maryland, and the Institute for Bioscience and Biotechnology Research (IBBR) of the University...
Positive results from the initial Phase 1 clinical trial in 80 healthy volunteers and complementary pre-clinical studies of the Sanaria® PfSPZ...
La mission de Sanaria consiste à développer et à commercialiser des vaccins antipaludéens à parasite entier capables de conférer une protection...
Sanaria widmet sich in erster Linie der Entwicklung und Vermarktung von auf vollständigen Parasiten basierenden Malaria-Impfstoffen, die ein hohes...
- Los productos para parásitos de la malaria y mosquitos y los servicios de ensayos están disponibles a la venta a través de Sanaria La misión de...
Sanaria's mission is to develop and commercialize whole-parasite malaria vaccines that confer high-level, long-lasting protection against malaria...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.